These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8791773)

  • 1. Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase.
    Kupfer D; Dehal SS
    Methods Enzymol; 1996; 272():152-63. PubMed ID: 8791773
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of tamoxifen, toremifene and their major human metabolites.
    Berthou F; Dréano Y
    J Chromatogr; 1993 Jun; 616(1):117-27. PubMed ID: 8376482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.
    Hukkanen J; Mäntylä M; Kangas L; Wirta P; Hakkola J; Paakki P; Evisalmi S; Pelkonen O; Raunio H
    Pharmacol Toxicol; 1998 Feb; 82(2):93-7. PubMed ID: 9498238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
    Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
    Dehal SS; Brodie AM; Kupfer D
    Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
    Mani C; Hodgson E; Kupfer D
    Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazole.
    Kedderis GL; Rickert DE
    Biochem Biophys Res Commun; 1983 Jun; 113(2):433-8. PubMed ID: 6870866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
    Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
    Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
    Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
    Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
    Crewe HK; Ellis SW; Lennard MS; Tucker GT
    Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.
    Jacolot F; Simon I; Dreano Y; Beaune P; Riche C; Berthou F
    Biochem Pharmacol; 1991 Jun; 41(12):1911-9. PubMed ID: 2039544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.
    Moroni P; Buronfosse T; Longin-Sauvageon C; Delatour P; Benoit E
    Drug Metab Dispos; 1995 Feb; 23(2):160-5. PubMed ID: 7736906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
    Mani C; Kupfer D
    Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.
    Williams DE; Katchamar S; Larsen-Su SA; Stresser DM; Dehal SS; Kupfer D
    Adv Exp Med Biol; 2001; 500():635-8. PubMed ID: 11765009
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
    Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
    Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS; Kupfer D
    Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
    Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
    Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes.
    Caputo O; Grosa G; Ceruti M; Rocco F; Biglino G
    Drug Metab Dispos; 1990; 18(5):771-8. PubMed ID: 1981735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.